Стратегия «Watch & Wait» в радикальном лечении рака прямой кишки: добиваемся полного ответа всеми способами?

نویسندگان

چکیده

In the last decade, strategy with refusal of surgical treatment for rectal cancer patients who have achieved complete tumor regression after neoadjuvant therapy been widely accepted and approved by clinical guidelines leading organizations. This demonstrates good long-term results that confirm its safety. However, lack sufficient observations, imperfection methods registering a response, disagreements about optimal timing assessing effect performed stimulate continuation research.

برای دانلود باید عضویت طلایی داشته باشید

برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Simulating watch and wait for rectal cancer.

for decades, it has been accepted that surgical resection is the cornerstone for the curative treatment of rectal cancer. Conventional treatment for patients with locally advanced stages ii and iii rectal cancers has included preoperative radiation with concurrent chemotherapy, before radical resection, to improve local control. unfortunately, surgery is not without its risk for serious complic...

متن کامل

Watch and wait after neoadjuvant therapy for rectal cancer.

One of the most exciting, although contentious, areas of rectal cancer management in the past decade has been complete response after neoadjuvant chemoradiotherapy (CRT) with a ‘watch-and-wait’ policy in selected patients. Recent publications1–3 have added considerably to our knowledge on this complex topic, where sustained clinical, endoscopic and radiological response allows the consideration...

متن کامل

Watch-and-Wait as a Therapeutic Strategy in Rectal Cancer

Purpose of Review Pathological complete response is seen in approximately one fifth of rectal cancer patients following neoadjuvant chemoradiation. Since these patients have excellent oncological outcomes, there has been a rapidly growing interest in organ preservation for those who develop a clinical complete response. We review the watch-and-wait strategy and focus on all aspects of this hot ...

متن کامل

Is watch and wait still acceptable for patients with low-grade follicular lymphoma?

Follicular lymphoma (FL) represents more than 20% of all non-Hodgkin lymphomas worldwide and approximately 30% of the non-Hodgkin lymphomas diagnosed in the United States. Although occasionally localized at the time of diagnosis, most patients have disseminated disease. However, patients are frequently asymptomatic, and this, in combination with a long median survival, led to the initial studie...

متن کامل

Treatment of indolent lymphomas from watch and wait to high dose therapy.

Indolent B-cell non-Hodgkin’s lymphomas (IBCNHL) represent a heterogenous group of chronic diseases [1]. Follicular lymphomas grades 1 and 2 (FL1/2) are by far the most common, accounting for approximately 20% of all NHL worldwide. Indolent IBC-NHL also include small lymphocytic lymphoma (SLL), which is the tissue counterpart of B-chronic lymphocytic leukemia (B-CLL); [2], lymphoplasmacytic lym...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Voprosy onkologii

سال: 2022

ISSN: ['0507-3758']

DOI: https://doi.org/10.37469/0507-3758-2022-68-5-548-554